Medindia

X

Pacific Bridge Medical to Host Taiwan Drug Registration Webinar

Thursday, May 13, 2010 General News J E 4
Advertisement

BETHESDA, Md., May 13 /PRNewswire/ -- Pacific Bridge Medical, a leading Asia medical consulting firm, is hosting a webcast on Taiwan Drug Registration and Regulatory Issues on May 26, 2010 at 11am EDT.

Taiwan is the sixth largest pharmaceutical market in the Asia Pacific region. It is among the wealthier Asian countries and boasts a solid national health care system. This webcast will give an overview of Taiwan and delve into the various regulatory issues and requirements for drug registration in Taiwan - http://www.pacificbridgemedical.com/services/regulatory/registration/taiwan-drugs. The types of drugs this presentation will cover include Western drugs, over-the-counter (OTC), and generic products.

This will be a live webcast with the presenter speaking from Taiwan. The speaker is Pacific Bridge Medical's Taiwanese partner who has over 20 years of experience in the pharmaceutical industry in Asia and Taiwan. There will be a 60-minute presentation followed by a 30-minute Q&A session. Sign up now by logging into http://www.pacificbridgemedical.com/webcasts/2010_05.php

About Pacific Bridge Medical (PBM)

PBM is a leading Asia medical consulting firm dedicated to assisting medical companies in Asia. PBM has helped hundreds of medical companies with business development and regulatory affairs in Asia since our founding in 1988. PBM assists medical device, drug, IVD, OTC, and biotech companies in Asia. Visit http://www.pacificbridgemedical.com for more information.

SOURCE Pacific Bridge Medical

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
GenVec Receives NASDAQ Notice of Minimum Bid Price...
S
Celsion's Phase III ThermoDox® HEAT Study Recommen...